Background: There is an acknowledged urgent need to gather valid epidemiological data in Ireland that provides accurate and reliable estimates of current and future dementia prevalence and facilitates the development of effective dementia... more
Background: There is an acknowledged urgent need to gather valid epidemiological data in Ireland that provides accurate and reliable estimates of current and future dementia prevalence and facilitates the development of effective dementia health and social policy. This study, commissioned by the Alzheimer Society of Ireland, examined the feasibility of developing a National Dementia Registry for Ireland. Methods: National and international patient registry literature was reviewed to identify registry functions, models, best-practice guidelines, and the legal, ethical, clinical, technology, and financial issues relevant to the creation of a dementia registry in Ireland. Following ethical approval, we conducted two focus groups with people with dementia and twenty-one expert interviews with representatives from Irish and UK research, health, and social care organisations, Irish patient registries and international dementia registries. Discussions followed an agreed structure, were audio-recorded, transcribed and analysed using inductive content analysis. Results: Six themes emerged from these analyses: registry function; registry data; data collection; data management; registry governance and legislation. Three cross-cutting superordinate themes were also identified: benefits and risks, barriers and facilitators, and dementia-specific challenges. Conclusion: These findings provide an evidence-base from which we draw key conclusions and recommend actions to develop a comprehensive National Dementia Registry for Ireland.
Background: Connecting currently existing, heterogeneous rare disease (RD) registries would greatly facilitate epidemiological and clinical research. To increase their interoperability, the European Union developed a set of Common Data... more
Background: Connecting currently existing, heterogeneous rare disease (RD) registries would greatly facilitate epidemiological and clinical research. To increase their interoperability, the European Union developed a set of Common Data Elements (CDEs) for RD registries.
Objectives: To implement the CDEs and the FAIR data principles in the Registry of Vascular Anomalies (VASCA).
Methods: We created a semantic model for the CDE and transformed this into a Resource Description Framework (RDF) template. The electronic case report forms (eCRF) were mapped to the RDF template and published in a FAIR Data Point (FDP).
Results: The FAIR VASCA registry was successfully implemented using Castor EDC (Electronic Data Capture) software.
Introduction: Annually a considerable number of people die because of breast cancer, a common disease among women also in Iran. Identifying risk factors and susceptible people can lead to prevention or at least early diagnosis. Among... more
Introduction: Annually a considerable number of people die because of breast cancer, a common disease among women also in Iran. Identifying risk factors and susceptible people can lead to prevention or at least early diagnosis. Among susceptibility risks, 5-10% of patients have a family history predisposing factor which can influence the risk of incidence among the family. Having a registry program can be a more practical way to screen high risk families for preventive planning. Method: Based on inclusion criteria, a questionnaire was prepared and after a pilot study on a small number of patients, actual data were collected on 400 patients and processed in SPSS 16.0. Results: Totally, 28.2%of the patients were younger than 40 years old and 36.8% had the included criteria for familial breast cancer (FBC). 102 patient's samples could be compared for receptor presentation. Similar to other studies, the number of triple negative breast cancers increased as the age decreased. Conclusion: The high percentage of patients with FBC among 400 cases in this study demonstrates that in order to design an infrastructural diagnostic protocol and screening of patients with FBC, a precise survey related to frequency and founder mutations of FBC is needed nationwide.
Annually a considerable number of people die because of breast cancer, a common disease among women also in Iran. Identifying risk factors and susceptible people can lead to prevention or at least early diagnosis. Among susceptibility... more
Annually a considerable number of people die because of breast cancer, a common disease among women also in Iran. Identifying risk factors and susceptible people can lead to prevention or at least early diagnosis. Among susceptibility risks, 5-10% of patients have a family history predisposing factor which can influence the risk of incidence among the family. Having a registry program can be a more practical way to screen high risk families for preventive planning. Based on inclusion criteria, a questionnaire was prepared and after a pilot study on a small number of patients, actual data were collected on 400 patients and processed in SPSS 16.0. Totally, 28.2%of the patients were younger than 40 years old and 36.8% had the included criteria for familial breast cancer (FBC). 102 patient's samples could be compared for receptor presentation. Similar to other studies, the number of triple negative breast cancers increased as the age decreased. The high percentage of patients with F...
